Acarix announces final outcome in the rights issue
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, ...
Acarix announces preliminary outcome of the Rights Issue
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, ...
Invitation to digital live presentation with Acarix
Acarix, a leader in acoustic and AI-based cardiac diagnostics, invites to a digital investor presentation on Friday October 13, 2023 at...
Acarix publishes prospectus in connection with the company’s fully guaranteed rights issue
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, ...
Acarix appoints industry veteran Fred Colen as acting CEO during temporary medical leave of CEO Helen Ljungdahl Round
Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces that CEO Helen Ljungdahl Round will be taking a temporary medi...
Announcement from Acarix’s extra general meeting
The extra general meeting of Acarix AB ("Acarix" or the "Company") was held today on 28 September 2023 and the following resolution was...
Acarix expands use of CADScor System into Osteopathic Medicine
Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announces expanded utilization of the CADScor® System into the...
Acarix changes Certified Adviser to Penser Bank AB
Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announces a change of Certified Adviser.Acarix AB has entered into...
Notice of Extra General Meeting in Acarix AB
The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened to the extra general meeting to be held on Th...
Acarix resolves on a rights issue of approximately SEK 54 million fully guaranteed by, among others, a Danish life science fund
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, ...
Acarix receives initial order from the emerging East African market
Acarix, a leader in acoustic and AI-based cardiac diagnostics, partners with Maeva Health, led by Dr. Peter Svalander, CEO, to launch t...
Acarix AB (publ) publishes Interim Report, April – June 2023
Traction in the US market reflects transition to a new expanded commercial modelIn 2022, we initiated the transition of Acarix to full ...